Biotech · Private company
Paion UK Ltd.
Track this companyFree. Adds Paion UK Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- MidazolamPhase 3 · BronchoscopyClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 3 · ColonoscopyClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 3 · ColonoscopyClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 3 · BronchoscopyClinicalTrials.gov · fetched Nov 12, 2026
- A. CNS 7056Phase 2 · SedationClinicalTrials.gov · fetched Nov 12, 2026
- B. CNS 7056Phase 2 · SedationClinicalTrials.gov · fetched Nov 12, 2026
- C. CNS 7056Phase 2 · SedationClinicalTrials.gov · fetched Nov 12, 2026
- CNS 7056Phase 2 · Procedural SedationClinicalTrials.gov · fetched Nov 12, 2026
- D. MidazolamPhase 2 · SedationClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 2 · Procedural SedationClinicalTrials.gov · fetched Nov 12, 2026
- AlcoholPhase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Abuse, DrugClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 1 · Abuse, DrugClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 1 · BioavailabilityClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 1 · Procedural SedationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Investigation of Remimazolam in Children Undergoing Sedation for Medical ProceduresPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 15, 2021ClinicalTrials.gov NCT04851717 · fetched Nov 12, 2026
- Oral Remimazolam With and Without Alcohol in Healthy Female SubjectsPHASE1 · COMPLETED · started May 30, 2017ClinicalTrials.gov NCT04113343 · fetched Nov 12, 2026
- A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and BioavailabilityPHASE1 · COMPLETED · started May 15, 2017ClinicalTrials.gov NCT03329014 · fetched Nov 12, 2026
- Absolute Oral Bioavailability of RemimazolamPHASE1 · COMPLETED · started Nov 3, 2015ClinicalTrials.gov NCT04113564 · fetched Nov 12, 2026
- Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing ColonoscopyPHASE3 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02532647 · fetched Nov 12, 2026
- Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant UsersPHASE1 · COMPLETED · started Jun 23, 2015ClinicalTrials.gov NCT04110535 · fetched Nov 12, 2026
- A Phase III Study of Remimazolam in Patients Undergoing BronchoscopyPHASE3 · COMPLETED · started Apr 1, 2015ClinicalTrials.gov NCT02296892 · fetched Nov 12, 2026
- A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy PatientsPHASE3 · COMPLETED · started Mar 30, 2015ClinicalTrials.gov NCT02290873 · fetched Nov 12, 2026
- Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing ColonoscopyPHASE2 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01145222 · fetched Nov 12, 2026
- Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI EndoscopyPHASE2 · COMPLETED · started Mar 1, 2009ClinicalTrials.gov NCT00869440 · fetched Nov 12, 2026